CIK 0001720893
- Non-accelerated filer
- Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821386754
- Phone
- +1 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 60,000 shares at $17.32 ($1,039,200)
- 4 Open-market sale CEO and President sold 64,500 shares at an average $18.97 ($1,223,313)
- 4 Open-market sale Chief Financial Officer sold 2,084 shares at $19.50 ($40,638)
- 4 Open-market sale Chief Scientific Officer sold 985 shares at $19.69 ($19,396)
- 4 Exercise or conversion CEO and President acquired 10,437 shares (option exercise)
Page 8 of 14 · 276 filings